Unearthing Parkinsons Secrets

TL;DR

23andMe collaborates with Michael J. Fox for Parkinson's research, offering discounted genetic testing and surveys to improve clinical trial efficacy.

Transcript

we launched the parkinson's initiative with michael j fox and the parkinson's institute in out here and we have individuals with parkinson's were given a discounted version of the 23andme so we've designed the 23andme site so that individuals can get access to their data they can fill out surveys specifically about parkinson's as well as about thei... Read More

Key Insights

• 👨‍🔬 Collaboration with Michael J. Fox and the Parkinson's Institute for research on Parkinson's disease.
• 🧑‍⚕️ Providing discounted genetic testing and health surveys to individuals with Parkinson's for data collection.
• ❓ Analysis of data collected to make discoveries for the Parkinson's community.
• 🌥️ Focus on large cohort development to address underpowered clinical trials.
• 👨‍🔬 Research on genetics and drug response to optimize treatment efficacy and safety.
• 💁 Long-term data collection for correlations between genetic information and disease progression.
• ❓ Integration with clinical trials to match patients with suitable trials.

Questions & Answers

Q: How does 23andMe's collaboration with Michael J. Fox benefit individuals with Parkinson's?

The collaboration provides discounted genetic testing and surveys to gather health data for research and clinical trial improvements, benefitting the Parkinson's community.

Q: What is the significance of gathering long-term data on Parkinson's progression?

Long-term data collection allows for correlations between genetic information and disease progression, potentially leading to valuable insights for treatment and management.

Q: How does 23andMe aim to address the issue of underpowered clinical trials?

By creating large cohorts of participants, 23andMe seeks to provide extensive data sets for better-powered clinical trials, optimizing efficacy and safety assessments for treatments.

Q: What is the focus of 23andMe's research regarding genetics and drug response?

23andMe concentrates on understanding the relationship between genetics and drug response, aiming to determine the effectiveness and safety of medications for individuals based on their genetic makeup.

Summary & Key Takeaways

• Collaboration between 23andMe, Michael J. Fox, and the Parkinson's Institute for Parkinson's research.

• Individuals with Parkinson's receive discounted 23andMe testing and can participate in surveys about their health and disease progression.

• Data collected from surveys is analyzed by researchers to make discoveries beneficial for the Parkinson's community.